Concepedia

Maruti Naik

MN

Statistics

Publications

6

Citations

476

H-Index

6

Active since

2013

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

Maruti Naik is an author at AstraZeneca (India) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2013–2014

6

Publications

6

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 162 citations

, , +14

Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis

Pravin S. Shirude, Prashanti Madhavapeddi, Maruti Naik et al. · Journal of Medicinal Chemistry · 2013 · 101 citations · Full text

, , +17

4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity

Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text

, , +16

Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System

Eknath V. Bellale, Maruti Naik, Varun VB et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

, , +17

Structure Guided Lead Generation for <i>M. tuberculosis</i> Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors

Maruti Naik, Anandkumar Raichurkar, Balachandra Bandodkar et al. · Journal of Medicinal Chemistry · 2014 · 45 citations · Full text

, , +17

1–5 of 6